InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,346.99
(
-0.11%
)
US TECH 100
18,488.00
(
-0.25%
)
Dow Jones
38,798.99
(
-0.22%
)
Brent Oil
79.40
(
0.00%
)
Bitcoin
69,270.86
(
-0.05%
)
Post# of 460718
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

RedShoulder

Send PM Follow Ignore
Followers 156
Posts 6362
Boards Moderated 1
Alias Born 08/06/2004

RedShoulder

Member Level

Re: None

Wednesday, 09/28/2022 12:36:50 PM

Wednesday, September 28, 2022 12:36:50 PM

Post# of 460718
Due Diligence for new eyes:

AVXL has a pipeline of 11 trials and 6 in pre-clinical; and a portfolio of 4 drugs.

A2-73 Blarcamesine for:
Alzheimer's Disease.
Parkinson's Disease.
Rett Syndrome.
Infantile Spasms.
Fragile X.
Angelman's Syndrome.
Undisclosed Rare disease.

A3-71:
Frontotemporal Dementia (FTD).
Neurodegenterative Disease.

A1-41:
Depression.
Stroke.
Neurodegenterative Disease.

A-1066
Visceral Pain
Acute & Neuropathic Pain.

Source link:
https://www.anavex.com/_files/ugd/79bcf7_3cc5b85e0f1d49bb84e60f933ecbbea8.pdf

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • SONGD • Jun 7, 2024 10:15 AM

Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM

Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM

Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM

Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM

IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM

Start posting your company's news
Only $200 per official company press release!